DL-Norepinephrine (tartrate)

DL-Norepinephrine tartrate is a neurotransmitter, which targets adrenergic receptors, and causes large-amplitude sleep-like electrical activity in the neocortex and suppresses electroencephalography (EEG) activity in the hippocampus. DL-Norepinephrine tartrate results in head shake, difficulty walking, and frequent posture changes in rats model[1].

Product Specifications

CAS Number

[3414-63-9]

UNSPSC

12352005

Hazard Statement

H300+H310+H330

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/dl-norepinephrine-tartrate.html

Purity

95.04

Solubility

DMSO : 11.67 mg/mL (ultrasonic) |H2O : 35 mg/mL (ultrasonic)

Smiles

OC1=CC=C(C(O)CN)C=C1O.O=C(O)[C@H](O)[C@@H](O)C(O)=O

Molecular Formula

C12H17NO9

Molecular Weight

319.26

Precautions

H300+H310+H330

References & Citations

[1]Hansen MG, et al., The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat. Psychopharmacologia. 1973 Feb 27;29 (1) :33-44.